Literature DB >> 5505155

Differences between the biliary excretion of tri [14C] methyl-(3-hydroxy-phenyl) ammonium iodide in Wistar and Gunn rats.

T N Calvey, S M Somani, A Wright.   

Abstract

1. The biliary excretion of [(14)C]trimophonium iodide [tri[(14)C]methyl(3-hydroxyphenyl)ammonium iodide] was studied in normal Wistar animals and in jaundiced homozygous Gunn rats. 2. In normal Wistar rats small amounts of radioactivity (approx. 3% of the dose in 4h) were excreted in bile as two glucuronide conjugates, i.e. [(14)C]trimophonium glucuronide [tri[(14)C]methyl-(3-oxyphenyl)ammonium glucuronide] (85%) and 3-di[(14)C]methylaminophenyl glucuronide (10-15%). Only minor amounts of the unchanged drug were detected in bile. 3. In the homozygous jaundiced Gunn rat large amounts of radioactivity (26% of the dose in 4h) were eliminated in bile as [(14)C]trimophonium glucuronide alone. The quantitative excretion of this metabolite in Gunn rat bile was about ten times that in normal animals. 4. It is proposed that the biochemical lesion in the homozygous Gunn rat may indirectly affect the biliary transport of exogenous glucuronides across the canalicular membrane.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5505155      PMCID: PMC1179451          DOI: 10.1042/bj1190659

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  10 in total

1.  ON THE RELATIONSHIP BETWEEN LIPID SOLUBILITY AND MICROSOMAL METABOLISM OF DRUGS.

Authors:  P MAZEL; J F HENDERSON
Journal:  Biochem Pharmacol       Date:  1965-01-01       Impact factor: 5.858

2.  Enzymatic dealkylation of aminopyrine (pyramidon) and other alkylamines.

Authors:  B N LA DU; L GAUDETTE; N TROUSOF; B B BRODIE
Journal:  J Biol Chem       Date:  1955-06       Impact factor: 5.157

3.  Passage of drugs across body membranes.

Authors:  L S SCHANKER
Journal:  Pharmacol Rev       Date:  1962-12       Impact factor: 25.468

4.  Active transport of quaternary ammonium compounds into bile.

Authors:  L S SCHANKER; H M SOLOMON
Journal:  Am J Physiol       Date:  1963-05

5.  Relationship between the lipid solubility of drugs and their oxidation by liver microsomes.

Authors:  L E GAUDETTE; B B BRODIE
Journal:  Biochem Pharmacol       Date:  1959-08       Impact factor: 5.858

6.  Biliary excretion of injected conjugated and unconjugated bilirubin by normal and Gunn rats.

Authors:  I M ARIAS; L JOHNSON; S WOLFSON
Journal:  Am J Physiol       Date:  1961-05

7.  Congenital jaundice in rats, due to a defect in glucuronide formation.

Authors:  R SCHMID; J AXELROD; L HAMMAKER; R L SWARM
Journal:  J Clin Invest       Date:  1958-08       Impact factor: 14.808

8.  Distribution and fate of morphine in non-tolerant and tolerant dogs and rats.

Authors:  L A WOODS
Journal:  J Pharmacol Exp Ther       Date:  1954-10       Impact factor: 4.030

Review 9.  Formation, transport, metabolism and excretion of bilirubin.

Authors:  L M Gartner; I M Arias
Journal:  N Engl J Med       Date:  1969-06-12       Impact factor: 91.245

10.  The in vitro inhibition of the N-demethylation of pethidine by phenelzine (Phenethylhydrazine).

Authors:  B Clark
Journal:  Biochem Pharmacol       Date:  1967-12       Impact factor: 5.858

  10 in total
  4 in total

1.  The effect of organic anions on the biliary excretion of tri (14C) methyl-(3-hydroxyphenyl) ammonium O-glucuronide.

Authors:  T N Calvey; D J Back
Journal:  Biochem J       Date:  1971-02       Impact factor: 3.857

2.  The biliary excretion of [3H] lysergic acid diethylamide in Wistar and Gunn rats.

Authors:  D J Back; J K Singh
Journal:  Experientia       Date:  1976-05-15

3.  Studies on flavonoid metabolism. Biliary and urinary excretion of metabolites of (+)-(U- 14 C)catechin.

Authors:  N P Das; S P Sothy
Journal:  Biochem J       Date:  1971-11       Impact factor: 3.857

4.  Excretion of 14 C-edrophonium and its metabolites in bile: role of the liver cell and the peribiliary vascular plexus.

Authors:  D J Back; T N Calvey
Journal:  Br J Pharmacol       Date:  1972-03       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.